Breakthrough helps develop novel painkillers
Washington: A breakthrough has opened the door for the development of a new category of painkillers which may be effective in treating pain related to a number of conditions including cancer, AIDS, migraines and diabetes.
The painkillers, called TRPV1 antagonists, can be activated by pepper like chemicals and high temperatures.
These drugs block the TRPV1 channel, which is the same receptor responsible for the sensation of hotness from hot peppers.
However, clinical trials have revealed that TRPV1 antagonists cause hyperthermia, which is a dangerous, fever-like rise in body temperature.
The same channel is responsible for pain caused by these diverse stimuli. For a number of years, scientists have focused on the development of TRPV1 antagonists, but have been stymied by the dangerous hyperthermia side-effect.
The ground breaking project to eliminate the side-effect was led by Andrej A. Romanovsky at Barrow Neurological Institute at St. Joseph`s Hospital and Medical Centre in Arizona and included researchers from Arizona State University.
"We think we have found a recipe for making TRPV1 antagonists that do not have this fever-like side effect," says Romanovsky.
More from India
More from World
More from Sports
More from Entertaiment
- Dr Subhash Chandra Show: How will business be conducted in the future?
- Dr Subhash Chandra Show: How will business be conducted in the future? - Part II
- Dr Subhash Chandra Show: How will business be conducted in the future? - Part III
- Dr Subhash Chandra Show: How will business be conducted in the future? - Part IV
- Terrorist outfit IS releases hitlist; 4000 people including 285 Indians targeted
- Unlikely Kerala nursing student was forced to drink toilet cleaner, says Karnataka police
- Coolpad launches virtual reality headset at Rs 999
- Grounds need to be watered, match or no match: Narendra Modi on IPL drought row
- What is Article 50? The key to Brexit
- GER V SVK: Slovakia eye Germany upset in Euro 2016 pre-quarters